Focus J81F, J83F, J41F, J43F Pacing Leads
510(k) K896742
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK896742 | Date17 Jul 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Focus J81F, J83F, J41F, and J43F Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for use in cardiac pacing systems. These leads facilitate electrical stimulation of the heart to regulate rhythm, ensuring proper cardiac function in patients requiring pacing support.
These leads are supplied sterile and intended for single-use implantation within the cardiovascular system. They are regulated under FDA 510(k) clearance (K896742) and fall under product code DTB, adhering to regulation 870.3680. Manufactured by Ela Medical, Inc., they are intended for use in Class 3 medical devices within the cardiovascular specialty.
Other devices from Ela Medical, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these pacing leads reusable or intended for single-use after implantation, and how does sterility factor into that decision?
These leads (J81F, J83F, J41F, J43F) are explicitly designed for single-use implantation only. They are supplied sterile by the manufacturer, Ela Medical, ensuring they meet infection control standards for one-time cardiovascular use. Reuse is not recommended or supported by the design or regulatory classification as permanent pacemaker electrodes.
What are the key differences between the J81F/J83F models and the J41F/J43F models in terms of intended use or features?
The provided data does not specify technical differences between the J81F/J83F and J41F/J43F models beyond their classification as permanent pacemaker electrodes for cardiac pacing. Both sets are regulated under the same FDA 510(k) clearance (K896742) and product code (DTB), implying they share core functionality for electrical heart stimulation. For precise model-specific features (e.g., electrode type, lead length, or fixation mechanism), refer to the manufacturer’s technical documentation.
How should these leads be stored to maintain their sterility and performance before use?
While the data does not detail specific storage instructions, sterile medical devices like these leads typically require sealed, sterile packaging and protection from contamination. Store them in a clean, dry environment away from direct sunlight or extreme temperatures until ready for use. Always follow Ela Medical’s included instructions for unpacking and handling to preserve sterility and functionality.
What regulatory pathway was followed for FDA clearance of these pacing leads, and which advisory committee was involved?
These leads were cleared via the traditional 510(k) pathway under FDA’s Cardiovascular (CV) Advisory Committee. The submission was deemed substantially equivalent (SESE) to a predicate device, with clearance granted on July 17, 1990 (decision code: SESE). The product code (DTB) and regulation number (870.3680) further confirm their classification as permanent pacemaker electrodes under Class 3 medical devices.